Cardiovascular Research in EMbarazo and MAternity (EMMA). Study on Heart Rate Variability and Hemodynamic Adaptations During Pregnancy and Postpartum.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorFundacin Biomedica Galicia Sur

About this trial

Heart rate variability (HRV) provides a non-invasive assessment of autonomic control of the nervous system over the heart. During pregnancy, the cardiovascular system adapts significantly, affecting HRV and hemodynamics. Studying the relationship between HRV and hemodynamic changes is critical to understanding and monitoring cardiovascular health during pregnancy and postpartum, and predicting potential complications.

Eligibility criteria

Qualifiers

Over 18 years of age

Pregnancy from the third month of gestation

No pre-existing cardiovascular disease

Good cognitive level

Disqualifiers

Diabetes mellitus

Hyperthyroidism

Hypothyroidism

Chronic hypertension diagnosed before pregnancy

Trial design

Treatments tested in this trial

  • Assessment of HRV and blood pressure

Treatment groups

242 Participants
are divided into 1 treatment group

Sponsors and collaborators